PTC Therapeutics, Inc. (PTCT)

SEC filing

PTC Therapeutics, Inc.

PTCT · CIK 1070081

4 · Jan 8, 2026 · Boulding Mark Elliott sold 6,618 shares at $77.31/share ($511.6K); exercised options for 3,376 shares

Boulding Mark Elliott sold 6,618 shares at $77.31/share ($511.6K); exercised options for 3,376 shares

xslF345X05/form4-01082026_050104.xml

xslF345X05/form4-01082026_050104.xmlSEC.gov

Graphics and non-inline formats (not embedded below).